SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-041731
Filing Date
2019-11-07
Accepted
2019-11-07 16:07:22
Documents
14
Period of Report
2019-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arna-8k_20191107.htm   iXBRL 8-K 40758
2 EX-99.1 arna-ex991_6.htm EX-99.1 270592
3 GRAPHIC guzoiim4j3vy000001.jpg GRAPHIC 2287
  Complete submission text file 0001564590-19-041731.txt   458507

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA arna-20191107.xsd EX-101.SCH 6209
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE arna-20191107_lab.xml EX-101.LAB 19044
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE arna-20191107_pre.xml EX-101.PRE 11729
14 EXTRACTED XBRL INSTANCE DOCUMENT arna-8k_20191107_htm.xml XML 3428
Mailing Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121
Business Address 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 858-453-7200
ARENA PHARMACEUTICALS INC (Filer) CIK: 0001080709 (see all company filings)

IRS No.: 232908305 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-31161 | Film No.: 191200342
SIC: 2834 Pharmaceutical Preparations